397 related articles for article (PubMed ID: 16800958)
1. [KIRs on human NK cells and in relation with HLA class I antigen--review].
Dou LP; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):627-30. PubMed ID: 16800958
[TBL] [Abstract][Full Text] [Related]
2. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.
Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P
Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415
[TBL] [Abstract][Full Text] [Related]
4. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
5. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
[TBL] [Abstract][Full Text] [Related]
6. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
Verheyden S; Schots R; Duquet W; Demanet C
Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
[TBL] [Abstract][Full Text] [Related]
7. KIR matching in hematopoietic stem cell transplantation.
Bignon JD; Gagne K
Curr Opin Immunol; 2005 Oct; 17(5):553-9. PubMed ID: 16085405
[TBL] [Abstract][Full Text] [Related]
8. An overview of methods required to evaluate donor NK cell alloreactivity for haploidentical haemopoietic stem cell transplantation.
Velardi A
Methods Mol Biol; 2012; 882():469-76. PubMed ID: 22665250
[TBL] [Abstract][Full Text] [Related]
9. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
10. Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.
Clausen J; Wolf D; Petzer AL; Gunsilius E; Schumacher P; Kircher B; Gastl G; Nachbaur D
Clin Exp Immunol; 2007 Jun; 148(3):520-8. PubMed ID: 17493020
[TBL] [Abstract][Full Text] [Related]
11. Genomic polymorphism and allogeneic hematopoietic transplantation outcome.
Mullighan CG; Petersdorf EW
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):19-27. PubMed ID: 16399580
[TBL] [Abstract][Full Text] [Related]
12. Killer immunoglobulin-like receptors.
Moretta L; Moretta A
Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
[TBL] [Abstract][Full Text] [Related]
13. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
[TBL] [Abstract][Full Text] [Related]
14. Determinants of antileukemia effects of allogeneic NK cells.
Leung W; Iyengar R; Turner V; Lang P; Bader P; Conn P; Niethammer D; Handgretinger R
J Immunol; 2004 Jan; 172(1):644-50. PubMed ID: 14688377
[TBL] [Abstract][Full Text] [Related]
15. Role of KIRs and KIR ligands in hematopoietic transplantation.
Velardi A
Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.
Davies SM; Ruggieri L; DeFor T; Wagner JE; Weisdorf DJ; Miller JS; Velardi A; Blazar BR
Blood; 2002 Nov; 100(10):3825-7. PubMed ID: 12393440
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
[TBL] [Abstract][Full Text] [Related]
18. KIR and KIR ligand polymorphism: a new area for clinical applications?
Falco M; Moretta L; Moretta A; Bottino C
Tissue Antigens; 2013 Dec; 82(6):363-73. PubMed ID: 24498992
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
[TBL] [Abstract][Full Text] [Related]
20. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]